Blueberry AK - 14G - Cannabis Flower Flower
License holder: urbanXtracts - Tested May 22, 2026
Lot: UXT-FLW-052026-BAK-14G · Sample: SNYURB0520-PFCU-0027066
29.53%
Total Δ9-THC
Total CBD
1.93%
Total Terpenes
THC-A converts to THC when heated (decarboxylation). Total Δ9-THC = (Δ9-THC) + (THC-A × 0.877) per NYS regulation.
93 tests reported
2 detections without a listed limit
Aerobic Bacteria: 15,635 CFU/g — no listed limit
Yeast & Mold: 125,918 CFU/g — no listed limit
4 more detected.
FM Mammal Excrement
Absent
FM Other
0 %
FM Stems
0 %
foreign matter
ND
| Analyte | Result | Limit | Status |
|---|---|---|---|
| FM Mammal Excrement | Absent | - | Pass |
| FM Other | 0 % | 2 % | Pass |
| FM Stems | 0 % | 5 % | Pass |
| foreign matter | - | Pass |
Antimony
ND
Arsenic
ND
Cadmium
ND
Chromium
0.305 ug/g
Copper
6.355 ug/g
Lead
ND
Mercury
ND
Nickel
ND
| Analyte | Result | Limit | Status |
|---|---|---|---|
| Antimony | 2 ug/g | Pass | |
| Arsenic | 0.2 ug/g | Pass | |
| Cadmium | 0.2 ug/g | Pass | |
| Chromium | 0.305 ug/g | 110 ug/g | Pass |
| Copper | 6.355 ug/g | 30 ug/g | Pass |
| Lead | 0.5 ug/g | Pass | |
| Mercury | 0.1 ug/g | Pass | |
| Nickel | 5 ug/g | Pass |
Aspergillus Flavus
ND
Aspergillus Fumigatus
ND
Aspergillus Niger
ND
Aspergillus Terreus
ND
Salmonella
ND
E. Coli
ND
Aerobic Bacteria
15,635 CFU/g
Yeast & Mold
125,918 CFU/g
| Analyte | Result | Limit | Status |
|---|---|---|---|
| Aspergillus Flavus | ND | 0 CFU/g | Pass |
| Aspergillus Fumigatus | ND | 0 CFU/g | Pass |
| Aspergillus Niger | ND | 0 CFU/g | Pass |
| Aspergillus Terreus | ND | 0 CFU/g | Pass |
| Salmonella | ND | 0 CFU/g | Pass |
| E. Coli | ND | 0 CFU/g | Pass |
| Aerobic Bacteria | 15,635 CFU/g | - | Unknown |
| Yeast & Mold | 125,918 CFU/g | - | Unknown |
B1
—
B2
—
G1
—
G2
—
Ochratoxin A
ND
Total Aflatoxins
ND
| Analyte | Result | Limit | Status |
|---|---|---|---|
| B1 | - | Unknown | |
| B2 | - | Unknown | |
| G1 | - | Unknown | |
| G2 | - | Unknown | |
| Ochratoxin A | 20 | Pass | |
| Total Aflatoxins | 20 | Pass |
Abamectin
ND
Acephate
ND
Acequinocyl
ND
Acetamiprid
ND
Aldicarb
ND
Azadirachtin
ND
Azoxystrobin
ND
Bifenazate
ND
Bifenthrin
ND
Boscalid
ND
Captan
ND
Carbaryl
ND
Carbofuran
ND
Chlorantraniliprole
ND
Chlordane
ND
Chlorfenapyr
ND
Chlormequat Chloride
ND
Chlorpyrifos
ND
Clofentezine
ND
Coumaphos
ND
Cyfluthrin
ND
Cypermethrin
ND
Daminozide
ND
Diazinon
ND
Dichlorvos
ND
Dimethoate
ND
Dimethomorph
ND
Ethoprophos
ND
Etofenprox
ND
Etoxazole
ND
Fenhexamid
ND
Fenoxycarb
ND
Fenpyroximate
ND
Fipronil
ND
Flonicamid
ND
Fludioxonil
ND
Hexythiazox
ND
Imazalil
ND
Imidacloprid
ND
Kresoxim Methyl
ND
Malathion
ND
Metalaxyl
ND
Methiocarb
ND
Methomyl
ND
Mevinphos
ND
MGK-264
ND
Myclobutanil
ND
Naled
ND
Oxamyl
ND
Paclobutrazol
ND
Methyl Parathion
ND
Permethrin
ND
Phosmet
ND
Piperonyl Butoxide
ND
Prallethrin
ND
Propiconazole
ND
Propoxur
ND
Pyrethrins
ND
Pyridaben
ND
Spinetoram
ND
Spiromesifen
ND
Spirotetramat
ND
Spiroxamine
ND
Tebuconazole
ND
Thiacloprid
ND
Thiamethoxam
ND
Trifloxystrobin
ND
| Analyte | Result | Limit | Status |
|---|---|---|---|
| Abamectin | 0.5 ug/g | Pass | |
| Acephate | 0.4 ug/g | Pass | |
| Acequinocyl | 2 ug/g | Pass | |
| Acetamiprid | 0.2 ug/g | Pass | |
| Aldicarb | 0.4 ug/g | Pass | |
| Azadirachtin | 1 ug/g | Pass | |
| Azoxystrobin | 0.2 ug/g | Pass | |
| Bifenazate | 0.2 ug/g | Pass | |
| Bifenthrin | 0.2 ug/g | Pass | |
| Boscalid | 0.4 ug/g | Pass | |
| Captan | 1 ug/g | Pass | |
| Carbaryl | 0.2 ug/g | Pass | |
| Carbofuran | 0.2 ug/g | Pass | |
| Chlorantraniliprole | 0.2 ug/g | Pass | |
| Chlordane | 1 ug/g | Pass | |
| Chlorfenapyr | 1 ug/g | Pass | |
| Chlormequat Chloride | 1 ug/g | Pass | |
| Chlorpyrifos | 0.2 ug/g | Pass | |
| Clofentezine | 0.2 ug/g | Pass | |
| Coumaphos | 1 ug/g | Pass | |
| Cyfluthrin | 1 ug/g | Pass | |
| Cypermethrin | 1 ug/g | Pass | |
| Daminozide | 1 ug/g | Pass | |
| Diazinon | 0.2 ug/g | Pass | |
| Dichlorvos | 1 ug/g | Pass | |
| Dimethoate | 0.2 ug/g | Pass | |
| Dimethomorph | 1 ug/g | Pass | |
| Ethoprophos | 0.2 ug/g | Pass | |
| Etofenprox | 0.4 ug/g | Pass | |
| Etoxazole | 0.2 ug/g | Pass | |
| Fenhexamid | 1 ug/g | Pass | |
| Fenoxycarb | 0.2 ug/g | Pass | |
| Fenpyroximate | 0.4 ug/g | Pass | |
| Fipronil | 0.4 ug/g | Pass | |
| Flonicamid | 1 ug/g | Pass | |
| Fludioxonil | 0.4 ug/g | Pass | |
| Hexythiazox | 1 ug/g | Pass | |
| Imazalil | 0.2 ug/g | Pass | |
| Imidacloprid | 0.4 ug/g | Pass | |
| Kresoxim Methyl | 0.4 ug/g | Pass | |
| Malathion | 0.2 ug/g | Pass | |
| Metalaxyl | 0.2 ug/g | Pass | |
| Methiocarb | 0.2 ug/g | Pass | |
| Methomyl | 0.4 ug/g | Pass | |
| Mevinphos | 1 ug/g | Pass | |
| MGK-264 | 0.2 ug/g | Pass | |
| Myclobutanil | 0.2 ug/g | Pass | |
| Naled | 0.5 ug/g | Pass | |
| Oxamyl | 1 ug/g | Pass | |
| Paclobutrazol | 0.4 ug/g | Pass | |
| Methyl Parathion | 0.2 ug/g | Pass | |
| Permethrin | 0.2 ug/g | Pass | |
| Phosmet | 0.2 ug/g | Pass | |
| Piperonyl Butoxide | 2 ug/g | Pass | |
| Prallethrin | 0.2 ug/g | Pass | |
| Propiconazole | 0.4 ug/g | Pass | |
| Propoxur | 0.2 ug/g | Pass | |
| Pyrethrins | 1 ug/g | Pass | |
| Pyridaben | 0.2 ug/g | Pass | |
| Spinetoram | 1 ug/g | Pass | |
| Spiromesifen | 0.2 ug/g | Pass | |
| Spirotetramat | 0.2 ug/g | Pass | |
| Spiroxamine | 0.2 ug/g | Pass | |
| Tebuconazole | 0.4 ug/g | Pass | |
| Thiacloprid | 0.2 ug/g | Pass | |
| Thiamethoxam | 0.2 ug/g | Pass | |
| Trifloxystrobin | 0.2 ug/g | Pass |
Community Notes
Sign in to add a note.
No notes yet
Be the first to share your thoughts on this product.
Similar Products
Based on terpene profile similarity
2406129F3-AT
Curaleaf
Lot: 7424 1017 7963 9355
12 shared terpenes
2503091F9-NM
Curaleaf
Lot: 5504 2899 6531 3150
11 shared terpenes
Solventless 1g Galactic Fusion - Indica
Stop 30 LLC
Lot: NY-SL-38-20260521-A
12 shared terpenes
2411227F5-ZK
Curaleaf
Lot: 2278 8928 3861 5632
11 shared terpenes
Plant, Preroll, ,
Curaleaf
Lot: 7973 4143 6844 4609
11 shared terpenes
Details
- Product Type
- Flower
- Lot/Batch
- UXT-FLW-052026-BAK-14G
- Sample ID
- SNYURB0520-PFCU-0027066
- NY Tracking #
- 1A41203000012C8000002297
- Laboratory
- ACT Laboratories of New York, LLC
- Lab Permit
- OCM-CPL-00001
- Analysis Date
- May 22, 2026